leadf
logo-loader
ASX:NOX

Noxopharm Ltd

Receive alerts
Market:
ASX
Market Cap:
$148.46 m
Price
0.52 AUD
Change
0.00%
52 weeks high
0.99
52 weeks low
0.35

In brief

Noxopharm Ltd (ASX:NOX) is an Australian clinical-stage drug development company.

The company is focused on new treatments for a broad range of solid tumour cancers and one for septic shock.

Noxopharm is also building a pipeline of drugs based on a unique and proprietary technology platform for other large markets of unmet medical need.

Snapshot

  • Noxopharm looks ahead to even more highly productive FY22 with clear therapeutic and commercial strategies
  • Noxopharm presses ahead with Veyonda® clinical activity over June quarter
  • Noxopharm to expand NOXCOVID program following positive phase 1 results